sibutramine -> σιμπουτραμίνηSibutramine
(trade name Meridia in the U.S. and Canada, Reductil in Europe and most other countries), usually as sibutramine hydrochloride monohydrate, is an orally administered agent for the treatment of obesity, as an appetite suppressant. It is a centrally-acting serotonin-norepinephrine reuptake inhibitor structurally related to amphetamines, although its mechanism of action is distinct.
Sibutramine is manufactured by Abbott Laboratories. It is classified as a Schedule IV controlled substance in the United States.Sibutramine